Get the Stockscreener App
0.00
100.00%
-2.07
Immunoprecise Antibodies Ltd stock is traded at $0.00, with a volume of 0.
It is down -100.00% in the last 24 hours and down -100.00% over the past month.
ImmunoPrecise Antibodies Ltd is an AI-driven biotherapeutic research, technology and scientifically robust life science company focused on the discovery and development of next-generation biologics. The Company combines scientific expertise with proprietary technologies such as its LENSai platform to accelerate drug discovery and improve decision-making across complex biological systems. IPA has several subsidiaries in North America and Europe, supporting global partners in advancing novel therapeutics, diagnostics, and translational research.
See More
Previous Close:
$2.07
Open:
$0
24h Volume:
0
Relative Volume:
0.00
Market Cap:
$89.08M
Revenue:
$16.77M
Net Income/Loss:
$-11.87M
P/E Ratio:
0.00
EPS:
-0.4742
Net Cash Flow:
$-5.90M
1W Performance:
-100.00%
1M Performance:
-100.00%
6M Performance:
-100.00%
1Y Performance:
-100.00%
1-Day Range:
$0.00
$0.00
1-Week Range:
$0.00
$0.00
52-Week Range:
$0.00
$3.2459
Immunoprecise Antibodies Ltd Stock (IPA) Company Profile
Name
Immunoprecise Antibodies Ltd
Sector
Industry
Phone
-
Address
-
Compare IPA with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
IPA
Immunoprecise Antibodies Ltd
|
0.00 | 89.08M | 16.77M | -11.87M | -5.90M | -0.4742 |
|
VRTX
Vertex Pharmaceuticals Inc
|
452.04 | 113.14B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
741.29 | 78.49B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
877.94 | 54.76B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
397.55 | 54.51B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
INSM
Insmed Inc
|
197.01 | 41.64B | 447.02M | -1.18B | -906.14M | -6.1812 |
Immunoprecise Antibodies Ltd Stock (IPA) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-02-22 | Initiated | H.C. Wainwright | Buy |
| Oct-25-21 | Initiated | The Benchmark Company | Buy |
Immunoprecise Antibodies Ltd Stock (IPA) Latest News
ImmunoPrecise Antibodies Ltd Stock Analysis and ForecastMarket Sentiment Surveys & Zero-Cost Stock Research by Professionals - earlytimes.in
How ImmunoPrecise Antibodies Ltd. stock responds to policy changes2025 Performance Recap & High Conviction Investment Ideas - Newser
Will ImmunoPrecise Antibodies Ltd. (TQB) stock benefit from infrastructure billWeekly Market Outlook & Low Risk High Win Rate Stock Picks - Newser
Is ImmunoPrecise Antibodies Ltd. (TQB) stock positioned for secular growthCPI Data & Fast Gaining Stock Strategy Reports - Newser
What earnings margins imply for ImmunoPrecise Antibodies Ltd. (TQB) stockWeekly Earnings Recap & Expert Approved Trade Ideas - Newser
Published on: 2025-12-03 04:40:50 - Newser
Will ImmunoPrecise Antibodies Ltd. (TQB) stock hit analyst forecastsWeekly Investment Recap & Weekly Watchlist of Top Performers - Newser
What momentum indicators show for ImmunoPrecise Antibodies Ltd. stockBull Run & Verified Technical Signals - Newser
Published on: 2025-12-02 06:55:07 - Newser
Will ImmunoPrecise Antibodies Ltd. (TQB) stock remain on Wall Street radarGap Down & AI Powered Trade Plan Recommendations - Newser
Will ImmunoPrecise Antibodies Ltd. (TQB) stock gain from lower interest ratesMarket Growth Review & High Accuracy Buy Signal Tips - Newser
ImmunoPrecise Antibodies (OTCMKTS:IPATF) Shares Down 5.6% – Should You Sell? - Defense World
How analysts rate ImmunoPrecise Antibodies Ltd. stock todayMarket Risk Analysis & Technical Buy Zone Confirmation - moha.gov.vn
Why ImmunoPrecise Antibodies Ltd. stock is seen as undervaluedJuly 2025 Closing Moves & High Accuracy Buy Signal Tips - moha.gov.vn
Why ImmunoPrecise Antibodies Ltd. stock appeals to analystsWeekly Trade Review & Detailed Earnings Play Strategies - moha.gov.vn
What drives ImmunoPrecise Antibodies Ltd stock priceEarnings Miss Alerts & Affordable Capital Growth - earlytimes.in
Is ImmunoPrecise Antibodies Ltd. stock positioned well for digital economyWeekly Risk Summary & Free Expert Approved Momentum Trade Ideas - newser.com
Is ImmunoPrecise Antibodies Ltd. (TQB) stock attractive for growth fundsWeekly Volume Report & Free AI Powered Buy and Sell Recommendations - newser.com
How ImmunoPrecise Antibodies Ltd. (TQB) stock reacts to Fed tighteningJuly 2025 Price Swings & Expert Verified Movement Alerts - newser.com
What RSI levels show for ImmunoPrecise Antibodies Ltd. (TQB) stockLayoff News & Verified Momentum Stock Alerts - newser.com
Is ImmunoPrecise Antibodies Ltd. stock attractive for ETFsJuly 2025 Decliners & Long-Term Growth Plans - newser.com
What earnings revisions data tells us about ImmunoPrecise Antibodies Ltd.July 2025 Spike Watch & Long-Term Investment Growth Plans - newser.com
Will ImmunoPrecise Antibodies Ltd. stock recover faster than peersTrade Volume Summary & Free Growth Oriented Trading Recommendations - newser.com
Can ImmunoPrecise Antibodies Ltd. stock surprise with earnings upsideMarket Activity Recap & Weekly High Conviction Trade Ideas - newser.com
How sentiment analysis helps forecast ImmunoPrecise Antibodies Ltd.July 2025 Big Picture & Expert Curated Trade Setup Alerts - newser.com
Chart overlay techniques for tracking ImmunoPrecise Antibodies Ltd.July 2025 Closing Moves & Daily Profit Maximizing Trade Tips - newser.com
Why ImmunoPrecise Antibodies Ltd. stock is considered a top pick2025 Top Gainers & Step-by-Step Trade Execution Guides - newser.com
Will earnings trigger a reversal in ImmunoPrecise Antibodies Ltd.2025 Winners & Losers & Weekly Setup with High ROI Potential - newser.com
Immunoprecise Antibodies Ltd Stock (IPA) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.08%
0.91%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):